Enlivex Therapeutics Ownership | Who Owns Enlivex Therapeutics?


OverviewForecastFinancialsChart

Enlivex Therapeutics Ownership Summary


Enlivex Therapeutics is owned by 0.25% institutional investors, 5.59% insiders, and 94.16% retail investors. Armistice capital is the largest institutional shareholder, holding 10.38% of ENLV shares. Dolphin 90/10 IL is the top mutual fund, with 0.20% of its assets in Enlivex Therapeutics shares.

ENLV Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEnlivex Therapeutics0.25%5.59%94.16%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital2.21M10.38%$2.58M
Millennium management633.85K2.98%$741.60K
Morgan stanley244.89K1.31%$347.75K
Renaissance158.99K0.75%$186.02K
Sigma investment counselors28.00K0.13%$32.76K
Two sigma securities22.36K0.11%$26.16K
Hrt financial lp16.88K0.08%$19.00K
Jane street group12.87K0.06%$15.06K
Susquehanna group, llp11.16K0.05%$13.06K
Geode capital management10.42K0.05%$12.19K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Armistice capital2.21M0.04%$2.58M
Two sigma securities22.36K0.00%$26.16K
Sigma investment counselors28.00K0.00%$32.76K
Ars wealth advisors group10.00K0.00%$11.70K
Millennium management633.85K0.00%$741.60K
Activest wealth management1.00K0.00%$1.17K
Renaissance158.99K0.00%$186.02K
Bfsg1.00K0.00%$1.17K
Red tortoise150.000.00%$176.00
Hrt financial lp16.88K0.00%$19.00K

Top Buyers

HolderShares% AssetsChange
Millennium management633.85K0.00%633.85K
Morgan stanley244.89K-172.77K
Renaissance158.99K0.00%84.20K
Armistice capital2.21M0.04%69.00K
Two sigma securities22.36K0.00%22.36K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---55.52K
Xtx topco---22.66K
Goldman sachs group---13.94K
Group one trading---5.73K
Ubs group16.00--3.20K

New Positions

HolderShares% AssetsChangeValue
Millennium management633.85K0.00%633.85K$741.60K
Two sigma securities22.36K0.00%22.36K$26.16K
Hrt financial lp16.88K0.00%16.88K$19.00K
Jane street group12.87K-12.87K$15.06K
Susquehanna group, llp11.16K-11.16K$13.06K

Sold Out

HolderChange
Qube research-1.00
Global retirement partners-11.00
Barclays-1.00K
Group one trading-5.73K
Goldman sachs group-13.94K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202411-47.62%53,240-97.92%-0.15%7-22.22%2-33.33%
Sep 30, 20242110.53%2,564,82323.06%1310.59%912.50%3-40.00%
Jun 30, 202419-2,084,178539.03%11360.97%833.33%5150.00%
Mar 31, 2024195.56%326,14673.06%1170.98%6-14.29%2-33.33%
Dec 31, 202318-188,457-23.18%157.74%7133.33%3-25.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dolphin 90/10 IL43.48K0.20%-
MTF TR TA-Growth37.59K0.17%-1.46K
IBI Mehaka TA-Growth13.30K0.06%-80.00
Fidelity Nasdaq Composite Index10.42K0.04%-
Dolphin Flexible7.42K0.03%-
I.B.I 90/105.75K0.03%-
Harel HTF TA All-Share IL3.86K0.02%9.00
I.B.I Government + 10% IL3.00K0.01%-
Dolphin75/25 IL787.000.00%-
Metiav 30/70 ESG Model IL457.000.00%457.00

Recent Insider Transactions


DateNameRoleActivityValue
Oct 09, 2015Murray Michael Anthony former SVP - OperationsSell$156.76K

ENLV Ownership FAQ


Who Owns Enlivex Therapeutics?

Enlivex Therapeutics shareholders are primarily institutional investors at 0.25%, followed by 5.59% insiders and 94.16% retail investors. The average institutional ownership in Enlivex Therapeutics's industry, Biotech Stocks , is 68.48%, which Enlivex Therapeutics falls below.

Who owns the most shares of Enlivex Therapeutics?

Enlivex Therapeutics’s largest shareholders are Armistice capital (2.21M shares, 10.38%), Millennium management (633.85K shares, 2.98%), and Morgan stanley (244.89K shares, 1.31%). Together, they hold 14.66% of Enlivex Therapeutics’s total shares outstanding.

Does Blackrock own Enlivex Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Enlivex Therapeutics.

Who is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested?

Armistice capital is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 2.21M Enlivex Therapeutics shares, valued at 2.58M$.

Who is the top mutual fund holder of Enlivex Therapeutics shares?

Dolphin 90/10 IL is the top mutual fund holder of Enlivex Therapeutics shares, with 0.20% of its total shares outstanding invested in 43.48K Enlivex Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools